These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25994468)

  • 1. [A simple but very complicated angioplasty: management of coronary artery perforation and dual antiplatelet therapy. A case report and literature review].
    Soriano F; Oreglia J; Bossi I; Colombo P; Piccalò G; De Marco F; Bruschi G; Klugmann S
    G Ital Cardiol (Rome); 2015 May; 16(5):311-5. PubMed ID: 25994468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous two-vessel very-late stent thrombosis of everolimus-eluting stents.
    Puri A; Saireddy R; McClean D
    J Invasive Cardiol; 2013 Mar; 25(3):E48-50. PubMed ID: 23468452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
    Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes with 6 months dual antiplatelet therapy after implantation of biolimus-A9 drug eluting coronary stents.
    Cockburn J; Pareek N; Poliacikova P; Saraf S; Williams R; Dhillon G; Robinson D; Gerber R; Hatrick R; Blows L; de Belder A; Hildick-Smith D
    Int J Cardiol; 2014 Mar; 172(1):185-9. PubMed ID: 24462139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late stent thrombosis of a second-generation drug- eluting stent.
    Karjalainen PP; Nammas W; Ylitalo A
    J Invasive Cardiol; 2012 Oct; 24(10):E225-7. PubMed ID: 23043049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful sealing of a coronary artery perforation with a mesh-covered stent.
    Fogarassy G; Apró D; Veress G
    J Invasive Cardiol; 2012 Apr; 24(4):E80-3. PubMed ID: 22477764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extremely late drug-eluting stent thrombosis: 2037 days after deployment.
    Layland J; Jellis C; Whitbourn R
    Cardiovasc Revasc Med; 2009; 10(1):55-7. PubMed ID: 19159856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year clinical outcome with the Endeavor™ zotarolimus-eluting stent in primary percutaneous coronary intervention for ST elevation myocardial infarction: the Endeavor™ primary PCI study (E-PPCI).
    Shelton RJ; Chitkara K; Singh R; Dorsch MF; Somers K; McLenachan JM; Blaxill JM; Wheatcroft SB; Blackman DJ; Greenwood JP
    J Interv Cardiol; 2011 Dec; 24(6):542-8. PubMed ID: 21883474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.
    Murray AT; Sederberg JH
    Semin Cardiothorac Vasc Anesth; 2011; 15(1-2):40-3. PubMed ID: 21840879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris.
    Mizoguchi T; Sawada T; Shinke T; Yamada S; Okamoto H; Kim SS; Takarada A; Yasaka Y
    Int J Cardiol; 2014 Feb; 171(2):224-30. PubMed ID: 24388538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac perforation complicated by cardiac tamponade and sealed with metallic coils].
    Martí V; Castaño C; Guiteras P; Vallés E; Domínguez de Rozas JM; Augé JM
    Rev Esp Cardiol; 2004 Oct; 57(10):990-2. PubMed ID: 15469797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.
    Caixeta A; Lansky AJ; Serruys PW; Hermiller JB; Ruygrok P; Onuma Y; Gordon P; Yaqub M; Miquel-Hebert K; Veldhof S; Sood P; Su X; Jonnavithula L; Sudhir K; Stone GW;
    JACC Cardiovasc Interv; 2010 Dec; 3(12):1220-8. PubMed ID: 21232715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.
    Di Lorenzo E; De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G
    JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
    De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E
    Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic abnormal vessel wall reaction after implantation of the first generation sirolimus-eluting stent: a case series.
    Mostafa AE; Richardt G; Abdel-Wahab M
    Cardiovasc Revasc Med; 2012; 13(3):196-200. PubMed ID: 22652316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study).
    Krucoff MW; Rutledge DR; Gruberg L; Jonnavithula L; Katopodis JN; Lombardi W; Mao VW; Sharma SK; Simonton CA; Tamboli HP; Wang J; Wilburn O; Zhao W; Sudhir K; Hermiller JB
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1298-309. PubMed ID: 22192371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed abrupt tamponade by isolated left atrial compression following coronary artery perforation during coronary angioplasty.
    Barbeau GR; Sénéchal M; Voisine P
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):562-5. PubMed ID: 16273592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.